|
CA2460345A1
(en)
*
|
2001-09-13 |
2003-03-20 |
Synta Pharmaceuticals Corp. |
2-aroylimidazole compounds for treating cancer
|
|
JP4445266B2
(ja)
*
|
2002-02-12 |
2010-04-07 |
ウイスコンシン アラムナイ リサーチ フオンデーシヨン |
Ａｈ受容体のリガンドとしてのインドールチアゾール化合物の合成
|
|
TW200503738A
(en)
*
|
2003-07-16 |
2005-02-01 |
Tzu Chi Buddhist General Hospital |
Method for extracting antineoplastic components from bupleurum scorzonerifolium
|
|
AU2004284420A1
(en)
|
2003-09-24 |
2005-05-06 |
Vertex Pharmaceuticals Incorporated |
4-azole substituted imidazole compositions useful as inhibitors or c-Met receptor tyrosine kinase
|
|
AU2004285831B2
(en)
*
|
2003-10-31 |
2011-09-15 |
Auckland Uniservices Limited |
Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
|
|
GB0403781D0
(en)
*
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Chemical compounds
|
|
MX2007003332A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
MX2007003318A
(es)
|
2004-09-20 |
2007-05-18 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como agentes terapeuticos.
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
CN101084211A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为治疗剂的用途
|
|
BRPI0515482A
(pt)
|
2004-09-20 |
2008-07-22 |
Xenon Pharmaceuticals Inc |
derivados heterocìclicos e seus usos como agentes terapêuticos
|
|
AU2005286728A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
|
|
WO2006128129A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
CA2618646A1
(en)
|
2005-06-03 |
2007-11-15 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
CA2617642A1
(en)
*
|
2005-08-09 |
2007-02-22 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
JP5460054B2
(ja)
*
|
2005-11-23 |
2014-04-02 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
腫瘍形成性ｒａｓ特異的細胞障害性化合物およびその使用法
|
|
US7960544B2
(en)
*
|
2005-12-16 |
2011-06-14 |
Ironwood Pharmaceuticals, Inc. |
Useful indole compounds
|
|
US7649098B2
(en)
*
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
WO2008005908A2
(en)
|
2006-07-07 |
2008-01-10 |
Forest Laboratories Holdings Limited |
Pyridoimidazole derivatives
|
|
WO2008085302A1
(en)
*
|
2006-12-20 |
2008-07-17 |
Merck & Co., Inc. |
Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
|
|
TW200920355A
(en)
*
|
2007-09-06 |
2009-05-16 |
Lexicon Pharmaceuticals Inc |
Compositions and methods for treating immunological and inflammatory diseases and disorders
|
|
US20110230464A1
(en)
*
|
2007-10-26 |
2011-09-22 |
Paul Goldsmith |
Purine derivatives useful as p13 kinase inhibitors
|
|
CA2721851A1
(en)
|
2008-05-30 |
2009-12-03 |
Genentech, Inc. |
Purine pi3k inhibitor compounds and methods of use
|
|
US8513221B2
(en)
|
2008-07-07 |
2013-08-20 |
Xcovery Holding, LLC |
PI3K isoform selective inhibitors
|
|
BRPI1009022A2
(pt)
|
2009-05-27 |
2016-03-08 |
Hoffmann La Roche |
"composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
|
|
EP2560640A1
(en)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
ES2536780T3
(es)
|
2010-07-14 |
2015-05-28 |
F. Hoffmann-La Roche Ag |
Compuestos de purina selectivos para I3 p110 delta, y métodos de uso
|
|
EP2606031B1
(en)
|
2010-08-20 |
2017-09-27 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
|
TW201500358A
(zh)
|
2010-12-16 |
2015-01-01 |
赫夫門羅氏藥廠股份有限公司 |
三環ｐｉ３ｋ抑制劑化合物及其使用方法
|
|
EP2714680B1
(en)
*
|
2011-05-27 |
2015-11-25 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
|
JP2014534228A
(ja)
|
2011-11-02 |
2014-12-18 |
シンタ ファーマシューティカルズ コーポレーション |
白金含有剤とｈｓｐ９０阻害剤の組合せ療法
|
|
CA2853799A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
|
|
US9402831B2
(en)
|
2011-11-14 |
2016-08-02 |
Synta Pharmaceutical Corp. |
Combination therapy of HSP90 inhibitors with BRAF inhibitors
|
|
CN108841778B
(zh)
*
|
2018-04-28 |
2022-05-17 |
大连普瑞康生物技术有限公司 |
一种红豆杉细胞组织培养物
|
|
US12404265B2
(en)
|
2020-08-04 |
2025-09-02 |
Nura Bio, Inc. |
Substituted pyridine derivatives as SARM1 inhibitors
|
|
CN116438171A
(zh)
|
2020-09-16 |
2023-07-14 |
努拉生物公司 |
作为sarm1抑制剂的取代的吡啶衍生物
|
|
EP4376840A4
(en)
*
|
2021-07-28 |
2025-05-21 |
Nura Bio, Inc. |
SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS
|
|
WO2023064486A1
(en)
*
|
2021-10-14 |
2023-04-20 |
Galileo Biosystems, Inc. |
Aryl hydrocarbon receptor (ahr) modulators and therapeutic uses thereof
|